Very high-risk prostate cancer: multimodality treatment will be the new frontier.

ABSTRACT:

SUBMITTER: Campobasso D 

PROVIDER: S-EPMC5656377 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature